The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 02, 2025

Filed:

Jan. 30, 2020
Applicant:

Siemens Healthcare Diagnostics Inc., Tarrytown, NY (US);

Inventors:

Manoj Sharma, Hockessin, DE (US);

Tatiana Lebedeva, Aston, PA (US);

Tatiana Mareeva, Haddonfield, NJ (US);

Yuriy Smirnov, Haddonfield, NJ (US);

Bogdan Draghici, Newark, DE (US);

Zhu Teng, Garnet Valley, PA (US);

Yi Feng Zheng, Wilmington, DE (US);

Heungyeung Yau, Wilmington, DE (US);

Nihmat Morjana, Newark, DE (US);

William Bedzyk, Odessa, DE (US);

Allison Dominowski, Middletown, DE (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/44 (2006.01); A61K 47/64 (2017.01); A61P 25/36 (2006.01); G01N 33/94 (2006.01);
U.S. Cl.
CPC ...
C07K 16/44 (2013.01); A61K 47/643 (2017.08); A61P 25/36 (2018.01); C07K 2317/10 (2013.01); C07K 2317/565 (2013.01); G01N 33/94 (2013.01);
Abstract

Antibodies that specifically bind naloxone or naltrexone are disclosed. Also disclosed are conjugates used in the production of the antibodies, as well as methods of producing the antibodies. Also disclosed are methods of using the antibodies in direct assays for naloxone or naltrexone. Further disclosed are methods of reducing naloxone or naltrexone interference in opiate assays using the antibodies.


Find Patent Forward Citations

Loading…